搜尋結果
A PBM Oligopoly: Three Companies Control 80% Of US Prescriptions – How Can We Fix It?
Forbes· 1 日前This investigation has shown a spotlight on a list of questionable ...
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’ ...
Forbes· 4 日前... announced interim late-stage trial results of its injectable HIV prevention drug ... ...
Matthew Stafford happy to start training camp with Rams after contract adjustment
Bastillepost· 2 日前Justice Department said. A leader of the powerful Sinaloa cartel for decades alongside ... ...
Is This Cheap Weight-Loss Drug Any Good?
Bloomberg· 3 日前Hi, it’s Ike in Boston. Knockoff weight-loss drugs have grown to a $1-billion-a-year ... ...
Drug giants eye China for deals despite growing Sino-US tensions
Reuters· 5 日前Some of the biggest global drugmakers, undeterred by mounting Sino-U.S. tensions, are scouring ...
AstraZeneca, Roche Intensify New Drug Push, Automakers Sink Post-Earnings | The Opening Trade ...
Bloomberg· 2 日前2 and half trillion dollar Thursday. That's the market cap of firms reporting < ... ...
US FDA flags dosing risks from compounded versions of Novo's weight-loss drug
Reuters· 16 小時前The health regulator said it had received reports of adverse events, some requiring ...
Novo Nordisk's Wegovy wins EU backing for reducing heart risks
CNBC· 1 日前The Danish pharmaceutical giant on Thursday said that the European ...
How AI Has Made The Networking Market Exciting Again
Forbes· 4 日前The networking infrastructure market is more dynamic and interesting than it’s been ... ...
Is Eli Lilly Stock Headed Toward $1300 Levels?
Forbes· 1 日前Eli Lilly stock (NYSE: LLY) has seen its stock rise by around 50% this year, outperforming the ...